Related Experiment Video
Updated: Jun 12, 2026

MRI and PET in Mouse Models of Myocardial Infarction
Published on: December 19, 2013
Assessment of Myocardial Scar; Comparison Between F-FDG PET, CMR and Tc-Sestamibi
Andrew Crean1, Sadia N Khan, L Ceri Davies
1Department of Radiology, Papworth Hospital, Papworth Everard, Cambridge, England.
Insights
Assessing myocardial scar in heart failure patients reveals significant differences between imaging techniques. Technetium-99m-Sestamibi (MIBI) and cardiac magnetic resonance (CMR) identify more scar than fluorodeoxyglucose (FDG), suggesting MIBI alone is insufficient for viability assessment.
Area of Science:
- Cardiology
- Nuclear Medicine
- Radiology
Background:
- Patients with heart failure and ischemic heart disease may benefit from revascularization if viable dysfunctional myocardium is present.
- Accurate identification of myocardial viability is crucial due to increased operative risks in these patients.
- This study compares three imaging modalities for detecting myocardial scar.
Purpose of the Study:
- To compare the utility of (99)Tc-Sestamibi (MIBI), (18)F-flurodeoxyglucose (FDG), and cardiac magnetic resonance (CMR) in detecting myocardial scar.
- To evaluate the agreement between these imaging modalities in assessing myocardial viability.
- To inform the selection of appropriate imaging techniques for patients with coronary artery disease and heart failure.
Main Methods:
- Prospective, descriptive study conducted at a tertiary cardiac center.
- 35 patients with coronary artery disease and heart failure symptoms were assessed.
- Myocardial scar was evaluated using MIBI, FDG, and CMR, with scar presence determined by a 20-segment model.
Main Results:
- MIBI identified significantly more nonviable scar segments compared to FDG and CMR (p = 0.0001).
- FDG identified the fewest scar segments per patient.
- Agreement between modalities was moderate to good, with the strongest agreement in the anterior wall and weakest in the inferior wall.
Conclusions:
- There is considerable variation among MIBI, FDG, and CMR in identifying scarred myocardium.
- MIBI and CMR detect more scar tissue than FDG.
- MIBI should not be used as the sole imaging modality for myocardial viability assessment in patients with coronary disease and heart failure.
Objective:
Patients with heart failure and ischaemic heart disease may obtain benefit from revascularisation if viable dysfunctional myocardium is present. Such patients have an increased operative risk, so it is important to ensure that viability is correctly identified. In this study, we have compared the utility of 3 imaging modalities to detect myocardial scar.
Design:
Prospective, descriptive study.
Setting:
Tertiary cardiac centre.
Patients:
35 patients (29 male, average age 70 years) with coronary artery disease and symptoms of heart failure (>NYHA class II).
Intervention:
Assessment of myocardial scar by (99)Tc-Sestamibi (MIBI), (18)F-flurodeoxyglucose (FDG) and cardiac magnetic resonance (CMR).
Outcome Measure:
The presence or absence of scar using a 20-segment model.
Results:
More segments were identified as nonviable scar using MIBI than with FDG or CMR. FDG identified the least number of scar segments per patient (7.4 +/- 4.8 with MIBI vs. 4.9 +/- 4.2 with FDG vs. 5.8 +/- 5.0 with CMR, p = 0.0001 by ANOVA). The strongest agreement between modalities was in the anterior wall with the weakest agreement in the inferior wall. Overall, the agreement between modalities was moderate to good.
Conclusion:
There is considerable variation amongst these 3 techniques in identifying scarred myocardium in patients with coronary disease and heart failure. MIBI and CMR identify more scar than FDG. We recommend that MIBI is not used as the sole imaging modality in patients undergoing assessment of myocardial viability.
More Related Videos
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies for Cardiovascular System V: CT
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System IV: CMRI

